Myocyte-specific enhancer factor 2c triggers transdifferentiation of adipose tissue-derived stromal cells into spontaneously beating cardiomyocyte-like cells
Open Access
- 15 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-16
- https://doi.org/10.1038/s41598-020-80848-3
Abstract
Cardiomyocyte regeneration is limited in adults. The adipose tissue-derived stromal vascular fraction (Ad-SVF) contains pluripotent stem cells that rarely transdifferentiate into spontaneously beating cardiomyocyte-like cells (beating CMs). However, the characteristics of beating CMs and the factors that regulate the differentiation of Ad-SVF toward the cardiac lineage are unknown. We developed a simple culture protocol under which the adult murine inguinal Ad-SVF reproducibly transdifferentiates into beating CMs without induction. The beating CMs showed the striated ventricular phenotype of cardiomyocytes and synchronised oscillation of the intracellular calcium concentration among cells on day 28 of Ad-SVF primary culture. We also identified beating CM-fated progenitors (CFPs) and performed single-cell transcriptome analysis of these CFPs. Among 491 transcription factors that were differentially expressed (≥ 1.75-fold) in CFPs and the beating CMs, myocyte-specific enhancer 2c (Mef2c) was key. Transduction of Ad-SVF cells with Mef2c using a lentiviral vector yielded CFPs and beating CMs with ~ tenfold higher cardiac troponin T expression, which was abolished by silencing of Mef2c. Thus, we identified the master gene required for transdifferentiation of Ad-SVF into beating CMs. These findings will facilitate the development of novel cardiac regeneration therapies based on gene-modified, cardiac lineage-directed Ad-SVF cells.This publication has 45 references indexed in Scilit:
- Concise Review: Genetic and Epigenetic Regulation of Cardiac Differentiation from Human Pluripotent Stem CellsThe International Journal of Cell Cloning, 2019
- Concise Review: Mesenchymal Stem Cells: From Roots to BoostThe International Journal of Cell Cloning, 2019
- Building a new strategy for treating heart failure using Induced Pluripotent Stem CellsJournal of Cardiology, 2018
- MiR‐148a promotes myocardial differentiation of human bone mesenchymal stromal cells via DNA methyltransferase 1 (DNMT1)Cell Biology International, 2018
- Human Pluripotent Stem Cell-Derived Cardiac Tissue-like Constructs for Repairing the Infarcted MyocardiumStem Cell Reports, 2017
- Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human PrimatesStem Cell Reports, 2016
- Gata4, Tbx5 and Baf60c induce differentiation of adipose tissue-derived mesenchymal stem cells into beating cardiomyocytesThe International Journal of Biochemistry & Cell Biology, 2015
- Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in Patients With Acute Myocardial Infarction Based on Individual Patient DataCirculation Research, 2015
- Accelerated direct reprogramming of fibroblasts into cardiomyocyte-like cells with the MyoD transactivation domainCardiovascular Research, 2013
- Molecular Regulation of Cardiac Chamber-Specific Gene ExpressionTrends in Cardiovascular Medicine, 2004